Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CRISPR-CAS13 SYSTEM FOR TREATING SOD1-ASSOCIATED DISEASES
Document Type and Number:
WIPO Patent Application WO/2023/024504
Kind Code:
A1
Abstract:
The invention provides an CRISPR-Cas13 system and a method of treating SOD1-associated diseases with the same.

Inventors:
YANG HUI (CN)
WANG XING (CN)
BAI MINGLIANG (CN)
Application Number:
PCT/CN2022/083476
Publication Date:
March 02, 2023
Filing Date:
March 28, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HUIGENE THERAPEUTICS CO LTD (CN)
CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE TECH CHINESE ACADEMY OF SCIENCES (CN)
International Classes:
C12N9/78; A61K35/17; C12N9/22; C12N15/10; C12N15/82
Domestic Patent References:
WO2018002762A12018-01-04
Foreign References:
US20210093667A12021-04-01
CN111511388A2020-08-07
CN111727247A2020-09-29
CN111328290A2020-06-23
Other References:
M. ALEJANDRA ZEBALLOS ET AL.: "Next-Generation CRISPR Technologies and Their Applications in Gene and Cell Therapy", TRENDS IN BIOTECHNOLOGY, vol. 39, no. 7, 30 June 2021 (2021-06-30), XP086612147, ISSN: 0167-7799, DOI: 10.1016/j.tibtech.2020.10.010
Attorney, Agent or Firm:
SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC (CN)
Download PDF: